ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
21 hedge funds and large institutions have $7.96M invested in Oncternal Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-20
Holders Change %
-48.78%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
9
Reduced
4
Closed
20
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$1K
Top Buyers
1 |
Millennium Management
New York
|
+$460K |
2 |
FHA
First Horizon Advisors
Memphis,
Tennessee
|
+$90K |
3 |
UBS Group
Zurich,
Switzerland
|
+$11.4K |
4 |
Wells Fargo
San Francisco,
California
|
+$2.86K |
5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.1K |
Top Sellers
1 |
BI
BVF Inc
San Francisco,
California
|
-$226K |
2 |
D.E. Shaw & Co
New York
|
-$99K |
3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$57K |
4 |
Renaissance Technologies
New York
|
-$57K |
5 |
Northern Trust
Chicago,
Illinois
|
-$54K |